Chevron Corp a un objectif de cours consensuel de $172 basé sur les évaluations de 25 analystes. Le plus élevé est $200, publié par B of A Securities le octobre 30, 2023. Le plus bas est $124, publié par Redburn Atlantic le avril 23, 2025. Les 3 évaluations d’analystes les plus récentes ont été publiées par Piper Sandler, Morgan Stanley et Raymond James le novembre 10, 2025, novembre 3, 2025 et octobre 17, 2025, respectivement. Avec un objectif de cours moyen de $168.67 entre Piper Sandler, Morgan Stanley et Raymond James, il existe une variation implicite de 7.38% upside pour Chevron Corp selon ces dernières évaluations d’analystes.
1calculé à partir des notes des analystes
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/10/2025 | 7.59% | Piper Sandler | $171 → $169 | Maintains | Overweight | |||
11/03/2025 | 12.68% | Morgan Stanley | $174 → $177 | Maintains | Overweight | |||
10/17/2025 | 1.86% | Raymond James | $170 → $160 | Reiterates | Outperform → Outperform | |||
10/17/2025 | 20.96% | Wells Fargo | → $190 | Initiates | → Overweight | |||
10/09/2025 | 5.04% | Scotiabank | $160 → $165 | Maintains | Sector Perform | |||
10/07/2025 | 0.59% | Barclays | $160 → $158 | Maintains | Equal-Weight | |||
09/15/2025 | 21.59% | Mizuho | $192 → $191 | Maintains | Outperform | |||
09/10/2025 | 17.77% | B of A Securities | $170 → $185 | Maintains | Buy | |||
08/20/2025 | 25.41% | UBS | $186 → $197 | Maintains | Buy | |||
08/20/2025 | -1.32% | Melius Research | → $155 | Initiates | → Hold | |||
08/18/2025 | 6.95% | Piper Sandler | $164 → $168 | Maintains | Overweight | |||
08/13/2025 | 22.23% | Mizuho | $186 → $192 | Maintains | Outperform | |||
08/04/2025 | 18.41% | UBS | $177 → $186 | Maintains | Buy | |||
07/31/2025 | 14.59% | Evercore ISI Group | → $180 | Reinstates | → Outperform | |||
07/23/2025 | 13.32% | Wells Fargo | $165 → $178 | Maintains | Overweight | |||
07/11/2025 | 1.86% | Scotiabank | $143 → $160 | Maintains | Sector Perform | |||
07/07/2025 | -0.69% | Barclays | $152 → $156 | Maintains | Equal-Weight | |||
07/02/2025 | 4.41% | Piper Sandler | $162 → $164 | Maintains | Overweight | |||
06/26/2025 | 5.04% | Wells Fargo | $164 → $165 | Maintains | Overweight | |||
05/13/2025 | 3.13% | Piper Sandler | $173 → $162 | Maintains | Overweight | |||
05/13/2025 | 0.59% | HSBC | $176 → $158 | Downgrade | Buy → Hold | |||
05/13/2025 | 18.41% | Mizuho | $188 → $186 | Maintains | Outperform | |||
05/05/2025 | 4.41% | Wells Fargo | $173 → $164 | Maintains | Overweight | |||
04/23/2025 | -21.06% | Redburn Atlantic | $156 → $124 | Downgrade | Neutral → Sell | |||
04/23/2025 | -3.23% | Barclays | $171 → $152 | Downgrade | Overweight → Equal-Weight | |||
04/15/2025 | 19.68% | Mizuho | $203 → $188 | Maintains | Outperform | |||
04/15/2025 | 10.13% | Wells Fargo | $184 → $173 | Maintains | Overweight | |||
04/11/2025 | -8.96% | Scotiabank | $160 → $143 | Downgrade | Sector Outperform → Sector Perform | |||
04/07/2025 | 17.77% | UBS | $194 → $185 | Maintains | Buy | |||
02/05/2025 | 29.23% | Mizuho | $194 → $203 | Maintains | Outperform | |||
02/05/2025 | 8.86% | Barclays | $174 → $171 | Maintains | Overweight | |||
02/04/2025 | 1.86% | Truist Securities | $164 → $160 | Maintains | Hold | |||
02/03/2025 | 23.5% | UBS | $195 → $194 | Maintains | Buy | |||
02/03/2025 | 11.41% | RBC Capital | $175 → $175 | Reiterates | Outperform → Outperform | |||
02/03/2025 | 17.14% | Wells Fargo | $188 → $184 | Maintains | Overweight | |||
02/03/2025 | 11.41% | Raymond James | $180 → $175 | Maintains | Outperform | |||
01/17/2025 | 14.59% | Raymond James | $175 → $180 | Maintains | Outperform | |||
01/13/2025 | 4.41% | Truist Securities | $160 → $164 | Maintains | Hold | |||
12/19/2024 | 10.13% | Piper Sandler | $184 → $173 | Maintains | Overweight | |||
12/09/2024 | 19.68% | Wells Fargo | $171 → $188 | Maintains | Overweight | |||
12/06/2024 | 1.86% | Truist Securities | $155 → $160 | Maintains | Hold | |||
12/03/2024 | 24.14% | UBS | $194 → $195 | Maintains | Buy | |||
11/26/2024 | 17.77% | Citigroup | $145 → $185 | Upgrade | Neutral → Buy | |||
11/07/2024 | 23.5% | Mizuho | $189 → $194 | Maintains | Outperform | |||
11/04/2024 | 23.5% | UBS | $192 → $194 | Maintains | Buy | |||
11/04/2024 | 11.41% | RBC Capital | $170 → $175 | Maintains | Outperform | |||
11/04/2024 | -1.32% | Truist Securities | $150 → $155 | Maintains | Hold | |||
11/04/2024 | 10.77% | Barclays | $168 → $174 | Maintains | Overweight | |||
10/17/2024 | 6.95% | B of A Securities | → $168 | Reinstates | → Buy | |||
10/10/2024 | 3.77% | Scotiabank | $180 → $163 | Maintains | Sector Outperform | |||
10/08/2024 | 22.23% | UBS | $189 → $192 | Maintains | Buy | |||
10/08/2024 | 8.23% | RBC Capital | $170 → $170 | Reiterates | Outperform → Outperform | |||
10/03/2024 | 6.95% | Barclays | $185 → $168 | Maintains | Overweight | |||
09/30/2024 | -4.51% | Truist Securities | $154 → $150 | Maintains | Hold | |||
09/27/2024 | 7.59% | Wells Fargo | $196 → $169 | Maintains | Overweight | |||
09/18/2024 | 20.32% | UBS | $192 → $189 | Maintains | Buy | |||
09/16/2024 | 20.32% | Mizuho | $205 → $189 | Maintains | Outperform | |||
08/06/2024 | 17.77% | Barclays | $203 → $185 | Maintains | Overweight | |||
08/05/2024 | 14.59% | RBC Capital | $190 → $180 | Maintains | Outperform | |||
08/05/2024 | -1.96% | Truist Securities | $156 → $154 | Maintains | Hold | |||
07/22/2024 | -0.69% | Truist Securities | $166 → $156 | Maintains | Hold | |||
07/18/2024 | — | Wolfe Research | — | Reinstates | → Peer Perform | |||
07/17/2024 | 6.32% | Bernstein | $183 → $167 | Downgrade | Outperform → Market Perform | |||
07/12/2024 | 14.59% | Scotiabank | $195 → $180 | Maintains | Sector Outperform | |||
05/13/2024 | 30.51% | Mizuho | $200 → $205 | Maintains | Buy | |||
05/10/2024 | 5.68% | Truist Securities | $156 → $166 | Maintains | Hold | |||
04/30/2024 | 13.32% | HSBC | $175 → $178 | Maintains | Buy | |||
04/30/2024 | 31.14% | Wells Fargo | $198 → $206 | Maintains | Overweight | |||
04/29/2024 | 1.86% | TD Cowen | $155 → $160 | Maintains | Hold | |||
04/18/2024 | 29.87% | Piper Sandler | $180 → $204 | Maintains | Overweight | |||
04/15/2024 | 10.77% | Raymond James | $170 → $174 | Maintains | Outperform | |||
04/11/2024 | 24.14% | Scotiabank | $170 → $195 | Upgrade | Sector Perform → Sector Outperform | |||
04/10/2024 | 29.23% | Barclays | → $203 | Initiates | → Overweight | |||
04/09/2024 | 25.41% | UBS | $185 → $197 | Maintains | Buy | |||
04/05/2024 | -0.69% | Truist Securities | $168 → $156 | Maintains | Hold | |||
04/04/2024 | 26.05% | Wells Fargo | $185 → $198 | Maintains | Overweight | |||
04/01/2024 | — | Goldman Sachs | — | Maintains | Buy | |||
03/20/2024 | 27.32% | Mizuho | $195 → $200 | Maintains | Buy | |||
03/14/2024 | 14.59% | Piper Sandler | $188 → $180 | Maintains | Overweight | |||
02/06/2024 | 1.86% | DZ Bank | → $160 | Downgrade | Buy → Hold | |||
02/05/2024 | 20.96% | RBC Capital | $185 → $190 | Maintains | Outperform | |||
01/23/2024 | -4.51% | TD Cowen | $170 → $150 | Downgrade | Outperform → Market Perform | |||
01/16/2024 | 8.23% | Scotiabank | → $170 | Downgrade | Sector Outperform → Sector Perform | |||
01/08/2024 | 17.14% | Jefferies | → $184 | Upgrade | Hold → Buy | |||
12/14/2023 | 17.77% | UBS | $194 → $185 | Maintains | Buy | |||
11/14/2023 | 24.14% | Mizuho | $215 → $195 | Maintains | Buy | |||
11/02/2023 | 15.86% | Bernstein | $184 → $182 | Upgrade | Market Perform → Outperform | |||
10/30/2023 | 27.32% | B of A Securities | $190 → $200 | Upgrade | Neutral → Buy | |||
10/30/2023 | 11.41% | Raymond James | $200 → $175 | Maintains | Outperform | |||
10/24/2023 | 7.59% | Truist Securities | $175 → $169 | Maintains | Hold | |||
10/24/2023 | 14.59% | RBC Capital | → $180 | Reiterates | Outperform → Outperform | |||
10/17/2023 | 27.96% | Morgan Stanley | $203 → $201 | Maintains | Equal-Weight | |||
10/17/2023 | 17.14% | Bernstein | → $184 | Initiates | → Market Perform | |||
10/04/2023 | 33.69% | UBS | $209 → $210 | Maintains | Buy | |||
10/02/2023 | 29.23% | Morgan Stanley | $198 → $203 | Maintains | Equal-Weight | |||
09/18/2023 | 36.87% | Mizuho | $209 → $215 | Maintains | Buy | |||
08/18/2023 | 26.05% | Morgan Stanley | $197 → $198 | Maintains | Equal-Weight | |||
08/17/2023 | 33.05% | UBS | $202 → $209 | Maintains | Buy | |||
08/16/2023 | — | Mizuho | — | Upgrade | Neutral → Buy | |||
08/01/2023 | 19.05% | Goldman Sachs | $166 → $187 | Maintains | Buy |
Le dernier objectif de prix pour Chevron (NYSE:CVX) a été rapporté par Piper Sandler le novembre 10, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $169.00 s'attendant à ce que CVX se rise dans les 12 prochains mois (un possible changement de 7.60% upside). 43 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
La dernière note d'analyste pour Chevron (NYSE:CVX) a été fournie par Piper Sandler, et Chevron maintenu leur note overweight.
La dernière amélioration pour Chevron Corp a eu lieu le novembre 26, 2024 lorsque Citigroup a augmenté leur objectif de prix à $185. Citigroup avait précédemment a neutral pour Chevron Corp.
La dernière réduction pour Chevron Corp a eu lieu le mai 13, 2025 lorsque HSBC a changé leur objectif de prix de $176 à $158 pour Chevron Corp.
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Chevron, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Chevron a été déposée le novembre 10, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers novembre 10, 2026.
Bien que les évaluations soient subjectives et changeront, la dernière note de Chevron (CVX) était un maintenu avec un objectif de prix de $171.00 à $169.00. Le prix actuel de Chevron (CVX) est de $157.07, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.